KAITLIN WILLIAMSON: Open Payments
NPI 1063862399 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 71 payments from 15 companies in 2025. Trend: 2023 $1,232 · 2024 $1,231 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $323 |
| Novo Nordisk Inc | 13 | $267 |
| PFIZER INC. | 5 | $105 |
| Lilly USA, LLC | 5 | $85 |
| Phathom Pharmaceuticals, Inc. | 5 | $66 |
| Ardelyx, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Boston Scientific Corporation | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
Products named: Ozempic, VRAYLAR, NURTEC ODT, MOUNJARO, VOQUEZNA, QULIPTA, Wegovy, UBRELVY.
Industry payments across NC — which companies pay providers there.
